RIBOTECT
LIVE

Serial Number

79268012

Owner

BioNTech SE

Attorney

Monica Riva Talley

Filing Date

Aug 6, 2019

Add to watchlist:

No watchlists yet
View on USPTO

RIBOTECT Trademark

Serial Number: 79268012 • Registration: 6171861

RIBOTECT is a trademark filed by BioNTech SE on August 6, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BioNTech SE (46 trademarks)

An der Goldgrube 12

Entity Type: 94

BIONTECH RNA PHARMACEUTICALS GMBH (12 trademarks)

AN DER GOLDGRUBE 12
55131 MAINZ 60430 , DE

Entity Type: 16

Trademark Details

Filing Date

August 6, 2019

Registration Date

October 13, 2020

Published for Opposition

July 28, 2020

Goods & Services

Chemical reagents for medical and veterinary purposes; Medical and pharmaceutical preparations comprising liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions for the treatment and prevention of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects or metabolic disorders; Medical and pharmaceutical preparations comprising, in particular, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and comprising additional active ingredients, in particular proteins or nucleid acids for the treatment and prevention of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects or metabolic disorders; Carriers and carrier systems, namely, drug delivery agents in the form of powders, tablets, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and capsules that provide controlled release of the active ingredients for pharmaceuticals for use in the treatment of cancer, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders

Medical and veterinary services in connection with cancer diseases, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders

Scientific research for medical and veterinary purposes, in particular for treatment of cancer, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders, using liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or emulsions

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 13, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jan 31, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 30, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 30, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 30, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 30, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 30, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 30, 2024 COAR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 19, 2021 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 20, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 29, 2021 FICS
FINAL DISPOSITION PROCESSED
Jan 29, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 13, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 13, 2020 R.PR
NOTIFICATION PROCESSED BY IB
Jul 31, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 28, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 28, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 15, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 15, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 8, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 20, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 28, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 28, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 28, 2020 TROA
REFUSAL PROCESSED BY IB
Dec 20, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 30, 2019 RFCS
REFUSAL PROCESSED BY MPU
Nov 30, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 10, 2019 RFCR
NON-FINAL ACTION WRITTEN
Nov 9, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 4, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 8, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 2, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 26, 2019 REPR